Nutrition for Cancer Survivors.
Cancer is a leading cause of morbidity and mortality worldwide with tremendous burden for the individual and the society [...]....
Benzocycloheptènes : Questions médicales fréquentes
Questions fréquentes et termes MeSH associés
Diagnostic 5
#1
Comment identifier les benzocycloheptènes ?
L'identification se fait par des techniques de spectroscopie et de chromatographie.
#2
Quels tests sont utilisés pour les benzocycloheptènes ?
Des tests de toxicité et d'efficacité sont réalisés en laboratoire.
#3
Les benzocycloheptènes sont-ils détectables dans le sang ?
Oui, ils peuvent être détectés par des analyses spécifiques dans des échantillons biologiques.
#4
Y a-t-il des marqueurs spécifiques pour ces composés ?
Des marqueurs biologiques peuvent indiquer l'exposition à ces composés.
#5
Peut-on utiliser l'imagerie pour les benzocycloheptènes ?
L'imagerie moléculaire peut aider à visualiser leur distribution dans les tissus.
Symptômes 5
#1
Quels sont les effets secondaires des benzocycloheptènes ?
Ils peuvent provoquer des nausées, des vertiges ou des réactions allergiques.
#2
Les benzocycloheptènes causent-ils des douleurs ?
Des douleurs peuvent survenir en cas de toxicité ou d'allergie.
#3
Y a-t-il des symptômes neurologiques associés ?
Oui, des symptômes comme des maux de tête ou des troubles de la coordination peuvent apparaître.
#4
Peut-on observer des symptômes cutanés ?
Des éruptions cutanées peuvent survenir en cas de réaction allergique.
#5
Les benzocycloheptènes affectent-ils le système respiratoire ?
Une exposition excessive peut entraîner des irritations respiratoires.
Prévention 5
#1
Comment prévenir l'exposition aux benzocycloheptènes ?
Utiliser des équipements de protection et suivre les protocoles de sécurité en laboratoire.
#2
Y a-t-il des formations pour manipuler ces composés ?
Oui, des formations spécifiques sont souvent requises pour les chercheurs.
#3
Quels sont les risques en milieu industriel ?
Les travailleurs peuvent être exposés à des niveaux élevés sans protection adéquate.
#4
Des réglementations existent-elles pour leur usage ?
Oui, des réglementations strictes encadrent leur utilisation en laboratoire et en industrie.
#5
Comment évaluer les risques d'exposition ?
Des évaluations de risque doivent être effectuées régulièrement dans les environnements de travail.
Traitements 5
#1
Comment traiter une intoxication aux benzocycloheptènes ?
Le traitement inclut l'élimination de l'exposition et des soins symptomatiques.
#2
Y a-t-il des antidotes pour ces composés ?
Actuellement, il n'existe pas d'antidote spécifique pour les benzocycloheptènes.
#3
Quels médicaments peuvent aider en cas d'allergie ?
Des antihistaminiques peuvent être utilisés pour traiter les réactions allergiques.
#4
Les benzocycloheptènes nécessitent-ils une hospitalisation ?
Une hospitalisation peut être nécessaire en cas de symptômes graves.
#5
Comment gérer les effets à long terme ?
Un suivi médical régulier est recommandé pour surveiller les effets à long terme.
Complications 5
#1
Quelles complications peuvent survenir avec ces composés ?
Des complications comme des lésions organiques peuvent survenir en cas d'exposition prolongée.
#2
Les benzocycloheptènes peuvent-ils causer des cancers ?
Des études suggèrent un potentiel cancérigène, mais des recherches supplémentaires sont nécessaires.
#3
Y a-t-il des effets sur la reproduction ?
Des effets néfastes sur la reproduction ont été observés dans certaines études animales.
#4
Peut-on développer des allergies à long terme ?
Oui, des sensibilisations peuvent se développer avec une exposition répétée.
#5
Les benzocycloheptènes affectent-ils le système immunitaire ?
Une exposition prolongée peut altérer la fonction immunitaire, augmentant les infections.
Facteurs de risque 5
#1
Qui est le plus à risque d'exposition ?
Les travailleurs en laboratoire et en industrie chimique sont les plus exposés.
#2
L'âge influence-t-il la sensibilité ?
Oui, les jeunes et les personnes âgées peuvent être plus sensibles aux effets toxiques.
#3
Y a-t-il des prédispositions génétiques ?
Certaines prédispositions génétiques peuvent augmenter la sensibilité aux toxines.
#4
Les antécédents médicaux jouent-ils un rôle ?
Oui, des antécédents d'allergies ou de maladies respiratoires augmentent le risque.
#5
L'environnement de travail influence-t-il le risque ?
Oui, un environnement de travail mal ventilé augmente le risque d'exposition.
Contenu validé par Dr Olivier Menir
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 08/03/2025
Contenu vérifié selon les dernières recommandations médicales
Sous-catégories
8 au total
└─
Dibenzocycloheptènes
DibenzocycloheptenesD003986 -
D04.615.181.384
└─└─
Amitriptyline
AmitriptylineD000639 -
D04.615.181.384.100
└─└─
Butaclamol
ButaclamolD002069 -
D04.615.181.384.230
└─└─
Cyproheptadine
CyproheptadineD003533 -
D04.615.181.384.340
└─└─
Maléate de dizocilpine
Dizocilpine MaleateD016291 -
D04.615.181.384.380
└─└─
Nortriptyline
NortriptylineD009661 -
D04.615.181.384.535
└─└─
Protriptyline
ProtriptylineD011530 -
D04.615.181.384.650
└─└─└─
Loratadine
LoratadineD017336 -
D04.615.181.384.340.500
Auteurs principaux
Jiatian Li
1 publication dans cette catégorie
Affiliations :
- State Key Laboratory of Luminescent Materials and Devices, School of Chemistry and Chemical Engineering, South China University of Technology, Guangzhou 510641, P.R. China.
Publications dans "Benzocycloheptènes" :
Xiangwen Tan
1 publication dans cette catégorie
Affiliations :
- State Key Laboratory of Luminescent Materials and Devices, School of Chemistry and Chemical Engineering, South China University of Technology, Guangzhou 510641, P.R. China.
Publications dans "Benzocycloheptènes" :
Huanfeng Jiang
1 publication dans cette catégorie
Affiliations :
- State Key Laboratory of Luminescent Materials and Devices, School of Chemistry and Chemical Engineering, South China University of Technology, Guangzhou 510641, P.R. China.
Publications dans "Benzocycloheptènes" :
Wanqing Wu
1 publication dans cette catégorie
Affiliations :
- State Key Laboratory of Luminescent Materials and Devices, School of Chemistry and Chemical Engineering, South China University of Technology, Guangzhou 510641, P.R. China.
Publications dans "Benzocycloheptènes" :
Sources (10000 au total)
Hypertension in Cancer Survivors.
With increasing survival after cancer treatment, there is a need for long-term management of risk factors and chronic medical conditions to realize the full benefit of improvement of outcomes. Hyperte... A lot of newer anti-cancer therapies have been implicated in the development or worsening of hypertension. We summarize the latest data, explore associations between these therapies and hypertension, ...
Survival of cancer survivors with a new pancreatic cancer diagnosis.
Persons newly diagnosed with pancreas cancer and who have survived a previous cancer are often excluded from clinical trials, despite limited evidence about their prognosis. We examined the associatio... This US population-based cohort study included older adults (aged ≥66 years) diagnosed with pancreas cancer between 2005 and 2015 in the linked Surveillance, Epidemiology, and End Results-Medicare dat... Of 32,783 patients, 18.7% were previously diagnosed with another cancer. The most common previous cancers included prostate (29.0%), breast (18.9%), or colorectal (9.7%) cancer. More than half of prev... Given nearly equivalent survival compared to those without previous cancer, cancer survivors newly diagnosed with pancreas cancer should be considered for inclusion in pancreas cancer clinical trials....
Sleep disturbances among cancer survivors.
We investigated sleep disturbances among cancer survivors compared to similarly aged women without cancer history.... We identified 2067 women with a history of cancer other than breast or non-melanoma skin cancer at enrollment in the Sister Study, a US-wide cohort of women with a family history of breast cancer. Can... At enrollment, cancer survivors were on average 13.8 years (range=0, 62) from diagnosis. After adjustment for age at enrollment and depression, diabetes, hypertension, and menopausal status prior to t... Addressing sleep disturbances may improve well-being for cancer survivors....
Psychological and sexual problems of cancer survivors.
To explore: 1) the unmet needs of breast cancer patients; 2) the sexual needs experienced by breast cancer survivors; 3) the experiences of cancer patients at the time of relapse, including the biopsy... Interpretative phenomenological qualitative research by conducting direct in-depth interviews with participants who met the inclusion criteria. Sample analyzed were breast cancer survivors who had exp... Themes identified for breast cancer patients with unmet needs were i) overcoming health problems in breast cancer survivors; ii) need to access the best health services; iii) women's unmet information... Health-related problems of breast cancer survivors, such as fatigue and fear of cancer recurrence, can lead them to have trouble with social relationships, question their spirituality, and struggle wi...
Online nutrition information for cancer survivors.
This research aims to systematically review a comprehensive sample of websites (English-language) that provide information on nutrition after cancer treatment.... In consultation with cancer survivors and experts, we developed search strings for an internet search (incognito mode in Google Chrome) to be completed in six English-speaking countries (Ireland, the ... Initially, 720 links were found, with 159 eligible for inclusion. Those eligible for review were charity/support/non-governmental organisation weblinks (49.1%) that originated in the United States (42... Cancer survivors seeking nutrition information online may encounter difficulty locating advice, and where they do, it is unlikely to contain guidance on implementation into day-to-day life. This is co...
Management of Breast Cancer Survivors by Gynecologists.
Breast cancer patients commonly present to their OBGYN during the process of diagnosis and treatment of breast cancer both for specific gynecologic needs and for primary care follow up. These patients...
Fear of Cancer Recurrence in Adult Survivors of Childhood Cancer.
Fear of cancer recurrence is common among survivors of adult-onset cancer and associated with increased distress, functional impairment, and health care utilization. However, little is known about the... To characterize the prevalence of and risk factors for clinically significant fear of cancer recurrence in adult survivors of childhood cancer.... This cross-sectional investigation included participants recruited from the Childhood Cancer Survivor Study, a retrospective cohort study of long-term childhood cancer survivors treated at 31 institut... Clinically significant fear of cancer recurrence was assessed via the Fear of Cancer Recurrence Inventory-Short Form. Poisson regression models estimated prevalence ratios (PRs) with 95% CIs adjusted ... The final sample included 229 adult survivors of childhood cancer (115 female [50.2%]; mean [SD] age, 39.6 [9.9] years; mean [SD] time since diagnosis, 31.7 [8.4] years). Among survivors, 38 (16.6%; 9... Decades following treatment, one-third of childhood cancer survivors in this study reported elevated fear their cancer will recur or a subsequent malignant neoplasm will develop. Findings suggest that...
Financial toxicity in thyroid cancer survivors.
Financial burden and distress are high in patients with thyroid cancer. However, little has been done to evaluate potential interventions to mitigate financial toxicity in survivors. This review will ... Thyroid cancer incidence has nearly tripled in the past decades, and cost of treatment is predicted to rise more than other cancers over the next decade. With mean age of diagnosis at 51 years, most p... Thyroid cancer survivors have high rates of financial toxicity, and there remains need for longitudinal studies to evaluate how financial burden may change during the treatment process while also asse...
Needs assessment of cancer survivors in Alaska.
Little is known about cancer survivors' needs in Alaska. To address this knowledge gap, the Alaska Cancer Partnership conducted a needs assessment survey; our objectives were to identify unmet needs o... Cancer survivors were identified using data from the Alaska Cancer Registry. A random sample of 2,600 individuals was selected to receive the survey, which assessed unmet needs across the following do... We received 335 survey responses, for a response of 13.7%. Only 29.9% of cancer survivors expressed that all their needs were met. The most highly ranked unmet needs were as follows: help to reduce st... This assessment provided some of the first information regarding the needs of Alaska's cancer survivors. These results will be used by Alaska Cancer Partnership members across the state to inform heal...